8-K
Current Report
C4 Therapeutics, Inc. Filed Acc 0001564590-22-024179
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading cccc-8k_20220622.htm…